Puma Biotechnology, Inc. (PBYI) trades at a trailing P/E of 12.1, forward P/E of 30.3. Trailing earnings yield is 8.29%, forward earnings yield 3.30%. Graham Number is $6.00.
Criteria proven by this page:
Overall SharesGrow Score: 69/100 with 4/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -3.7 | -0.33 | 4.87 | 0.00 | - |
| 2017 | -12.6 | 2.43 | 68.93 | 132.64 | - |
| 2018 | -6.8 | 0.11 | 22.51 | 3.08 | - |
| 2019 | -4.5 | 0.16 | 19.43 | 1.25 | - |
| 2020 | -6.8 | 0.24 | -68.23 | 1.80 | - |
| 2021 | -4.2 | 0.08 | -50.51 | 0.49 | - |
| 2022 | 94,486.6 | -918.83 | 8.75 | 0.83 | - |
| 2023 | 9.5 | 0.00 | 3.82 | 0.87 | - |
| 2024 | 4.9 | 0.14 | 1.61 | 0.64 | - |
| 2025 | 9.6 | 0.00 | 2.28 | 1.30 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-8.29 | $0.00 | $-276M | - |
| 2017 | $-7.86 | $27.7M | $-292M | -1054.2% |
| 2018 | $-2.99 | $251M | $-113.6M | -45.3% |
| 2019 | $-2.13 | $272.3M | $-82.72M | -30.4% |
| 2020 | $-1.52 | $225.1M | $-60M | -26.7% |
| 2021 | $-0.72 | $253.2M | $-29.1M | -11.5% |
| 2022 | $0.02 | $228M | $912K | 0.4% |
| 2023 | $0.45 | $235.64M | $21.59M | 9.2% |
| 2024 | $0.62 | $230.47M | $30.28M | 13.1% |
| 2025 | $0.61 | $228.37M | $31.11M | 13.6% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $0.25 | $0.21 – $0.29 | $218M | $218M – $218M | 1 |
| 2027 | $0.50 | $0.49 – $0.51 | $218M | $218M – $218M | 1 |
| 2028 | $0.45 | $0.45 – $0.45 | $218M | $218M – $218M | 1 |
| 2029 | $0.35 | $0.35 – $0.35 | $217M | $217M – $217M | 1 |
| 2030 | $0.20 | $0.20 – $0.20 | $216M | $216M – $216M | 1 |
